Virgicin, a novel lanthipeptide from Virgibacillus sp. strain AK90 exhibits inhibitory activity against Gram-positive bacteria

Fighting biofilms with lantibiotics and other groups of bacteriocins

(2018) Harsh Mathur et al.   npj Biofilms and Microbiomes

Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability

(2018) Mengxin Geng et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Expanding the potential of NAI-107 for treating serious ESKAPE pathogens: synergistic combinations against Gram-negatives and bactericidal activity against non-dividing cells

(2017) Cristina Brunati et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

antiSMASH 4.0—improvements in chemistry prediction and gene cluster boundary identification

(2017) Kai Blin et al.   NUCLEIC ACIDS RESEARCH

Laterosporulin10: a novel defensin like Class IId bacteriocin from Brevibacillus sp. strain SKDU10 with inhibitory activity against microbial pathogens

(2016) Piyush Baindara et al.   MICROBIOLOGY-SGM

Production of bacteriocin by Virgibacillus salexigens isolated from “terasi”: a traditionally fermented shrimp paste in Indonesia

(2016) Takeshi Kobayashi et al.   WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY

Biochemical and genome sequence analyses of Megasphaera sp. strain DISK18 from dental plaque of a healthy individual reveals commensal lifestyle

(2016) Nayudu Nallabelli et al.   Scientific Reports

New insights into the mode of action of the lantibiotic salivaricin B

(2016) Abdelahhad Barbour et al.   Scientific Reports

Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?

(2016) Ana M. Guzman Prieto et al.   Frontiers in Microbiology

Characterization of the Antimicrobial Peptide Penisin, a Class Ia Novel Lantibiotic from Paenibacillus sp. Strain A3

(2015) Piyush Baindara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Class I and Class II Lanthipeptides Produced by Bacillus spp.

(2015) Joana Barbosa et al.   JOURNAL OF NATURAL PRODUCTS

Advances in the arsenal of tools available enabling the discovery of novel lantibiotics with therapeutic potential

(2014) Stephanie Kate Sandiford   Expert Opinion on Drug Discovery

The intramolecular disulfide-stapled structure of laterosporulin, a class IId bacteriocin, conceals a human defensin-like structural module

(2014) Pradip Kumar Singh et al.   FEBS Journal

The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics

(2014) Jerome Escano et al.   MicrobiologyOpen

An insulin-like growth factor-II intronic variant affects local DNA conformation and ovarian cancer survival

(2013) L. Lu et al.   CARCINOGENESIS

Lantibiotics: Promising candidates for future applications in health care

(2013) Jasmin Dischinger et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Structural characterization of thioether-bridged bacteriocins

(2013) Christopher T Lohans et al.   JOURNAL OF ANTIBIOTICS

Antimicrobial resistance and prudent drug use for Streptococcus suis

(2013) Norma P. Varela et al.   ANIMAL HEALTH RESEARCH REVIEWS

Discovery, Biosynthesis, and Engineering of Lantipeptides

(2012) Patrick J. Knerr et al.   Annual Review of Biochemistry

Functional study of risk loci of stem cell-associated gene lin-28B and associations with disease survival outcomes in epithelial ovarian cancer

(2012) L. Lu et al.   CARCINOGENESIS

Assignment of the Absolute Configuration of Polyfunctional Compounds by NMR Using Chiral Derivatizing Agents

(2012) J. M. Seco et al.   CHEMICAL REVIEWS

Clinical Resistance and Decreased Susceptibility in Streptococcus suis Isolates from Clinically Healthy Fattening Pigs

(2012) Bénédicte F. Callens et al.   Microbial Drug Resistance

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

(2012) Paul G. Arnison et al.   NATURAL PRODUCT REPORTS

Bacteriocins — a viable alternative to antibiotics?

(2012) Paul D. Cotter et al.   NATURE REVIEWS MICROBIOLOGY

Identification, Purification and Characterization of Laterosporulin, a Novel Bacteriocin Produced by Brevibacillus sp. Strain GI-9

(2012) Pradip Kumar Singh et al.   PLoS One

Anticancer effects of CAMEL peptide

(2010) Ryszard Smolarczyk et al.   LABORATORY INVESTIGATION

The identification of a low molecular mass bacteriocin, rhamnosin A, produced byLactobacillus rhamnosusstrain 68

(2009) R. Dimitrijević et al.   JOURNAL OF APPLIED MICROBIOLOGY

A model system to study antimicrobial strategies in endodontic biofilms

(2009) Carlos Estrela et al.   Journal of Applied Oral Science

New Ways to Squash Superbugs

(2009) Christopher T. Walsh et al.   SCIENTIFIC AMERICAN

The RAST Server: Rapid Annotations using Subsystems Technology

(2008) Ramy K Aziz et al.   BMC GENOMICS

N-terminal acetylation in paenibacillin, a novel lantibiotic

(2008) Zengguo He et al.   FEBS LETTERS

Statistical Optimization of Culture Components for Enhanced Bacteriocin Production byLactobacillus plantarumLR/14

(2008) Santosh Kumar Tiwari et al.   FOOD BIOTECHNOLOGY